Form 4: Corcept Therapeutics Officer Lyon Exercises Options and Sells Shares
SEC Form 4 Filing
Joseph Douglas Lyon, Chief Accounting & Technology Officer of Corcept Therapeutics, exercised stock options and sold shares on February 3, 2025, according to a Form 4 filing.
Summary
- On February 3, 2025, Joseph Douglas Lyon, Chief Accounting & Technology Officer of Corcept Therapeutics, exercised stock options to acquire 1,571 shares at $11.35 and 3,429 shares at $13.56.
- Lyon then sold 5,000 shares of common stock at $66.92 per share.
- Following these transactions, Lyon directly owns 8,759 shares of Corcept Therapeutics common stock.
- This includes shares underlying unvested restricted stock awards granted on various dates in 2024, which vest on the one-year anniversary of the grant date.
- The sale was executed under a pre-arranged 10b5-1 trading plan.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard insider transaction disclosure. The officer is exercising options and selling shares, which is a normal part of executive compensation.
Industry Context
This filing is a routine disclosure of insider transactions. It's common for executives to exercise stock options and sell shares for personal financial management.
Key Dates
| Date | Description |
|---|---|
| March 1, 2024 | Grant date of restricted stock awards (507 shares) that vest on the one-year anniversary. |
| June 3, 2024 | Grant date of restricted stock awards (1,232 shares) that vest on the one-year anniversary. |
| September 3, 2024 | Grant date of restricted stock awards (372 shares) that vest on the one-year anniversary. |
| December 2, 2024 | Grant date of restricted stock awards (215 shares) that vest on the one-year anniversary. |
| February 3, 2025 | Date of stock option exercise and share sale. |
| February 5, 2025 | Date of Form 4 filing. |
| February 8, 2029 | Expiration date of stock options exercised on February 3, 2025 at $11.35. |
| February 7, 2030 | Expiration date of stock options exercised on February 3, 2025 at $13.56. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.